Dermatology

4+ hour, 29+ min ago   (355+ words) Barzolvolimab outperforms placebo in patients with CSU and angioedema Written by Marisa Horak, MS | Oct. 5, 2026 The experimental therapy barzolvolimab can reduce disease activity in people with chronic spontaneous urticaria (CSU) — an inflammatory disorder characterized by recurrent itching and hives — who…...

57+ min ago   (378+ words) Underweight children with eczema who received dupilumab saw significant gains in body weight and BMI at 16 weeks compared with placebo, with the greatest gains observed among children aged 2 to 5 years, researchers reported. The findings, presented at the European Academy of…...

2+ hour, 33+ min ago   (185+ words) Oct 05, 2026, 11:42 ET SAN FRANCISCO, Oct. 5, 2026 /PRNewswire/ -- Vial, a clinical-stage biotechnology company, today announced that it has dosed the first patient in its Phase 1b clinical study of Vial's IL-13 x TSLP in patients with mild-to-moderate asthma. Vial's IL-13 x TSLP is a novel,…...

4+ hour, 15+ min ago   (311+ words) Established St. George practice marks the physician-led network's first location in Utah ST. GEORGE, Utah, Oct. 5, 2026/PRNewswire/ -- Golden State Dermatology (GSD) has expanded into Utah for the first time with St. George Dermatology, a full-service practice that has served Southern…...

5+ hour, 24+ min ago   (305+ words) Oct 05, 2026, 08:51 ET The new office is located at 249 S. Main Street, Suite 5, Barnegat, NJ 08005, inside Garden State Medical Center. Early morning and evening appointments will be available. As part of the expansion, Metropolitan Dermatology welcomes three experienced dermatology providers: Lisa Altman,…...

4+ hour, 41+ min ago   (693+ words) After months of dealing with red, itchy and scaly skin around her eyelids, Susan Scott of Groveland, Illinois decided it was time to stop trying to diagnose and treat the problem herself. She turned to a new virtual dermatology service…...

5+ hour, 26+ min ago   (1340+ words) Exploratory biomarker analysis provides deeper insights on the immunometabolic biology of psoriasis and potential impact of Taltz (ixekizumab) and Zepbound (tirzepatide) vs. Taltz alone in the TOGETHER-PsO study in adults with psoriasis and obesity Additionally, long-term durable outcomes with Olumiant…...

6+ hour, 11+ min ago   (257+ words) TuHURA Biosciences announced the issuance of a U.S. patent for their Delta Opioid Receptor (DOR) antagonist technology, which reprograms immunosuppressive cells to enhance cancer immunotherapy. This patent covers the use of DOR antagonists in combination therapies, including adoptive cellular immunotherapies like…...

6+ hour, 20+ min ago   (182+ words) Hand eczema is an inflammatory skin disease affecting the hands. When the disease persists for at least three months or recurs at least twice within a year, it is classified as CHE. A total of 15% of people will experience hand…...

6+ hour, 14+ min ago   (577+ words) The winner of the Nobel Prize for medicine was announced early this morning. Did you win your office pool? Do you think another research team was robbed? Send me all your hot takes at [email protected]. Now without further ado:…...